Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$49.38 - $63.75 $14,962 - $19,316
303 New
303 $18,000
Q2 2023

Aug 14, 2023

BUY
$47.99 - $60.21 $14,540 - $18,243
303 New
303 $15,000
Q3 2021

Nov 15, 2021

BUY
$59.21 - $78.66 $17,940 - $23,833
303 New
303 $20,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track O'Dell Group, LLC Portfolio

Follow O'Dell Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Dell Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Dell Group, LLC with notifications on news.